Logo image of CY4.MI

CY4GATE SPA (CY4.MI) Stock Fundamental Analysis

BIT:CY4 - Euronext Milan - IT0005412504 - Common Stock - Currency: EUR

4.91  -0.05 (-1.01%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CY4. CY4 was compared to 101 industry peers in the Software industry. CY4 scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. CY4 is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

CY4 had negative earnings in the past year.
CY4 had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CY4 reported negative net income in multiple years.
In multiple years CY4 reported negative operating cash flow during the last 5 years.
CY4.MI Yearly Net Income VS EBIT VS OCF VS FCFCY4.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

1.2 Ratios

CY4 has a worse Return On Assets (-9.19%) than 73.27% of its industry peers.
The Return On Equity of CY4 (-17.68%) is worse than 71.29% of its industry peers.
Industry RankSector Rank
ROA -9.19%
ROE -17.68%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CY4.MI Yearly ROA, ROE, ROICCY4.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150 -200

1.3 Margins

CY4 has a worse Gross Margin (48.18%) than 65.35% of its industry peers.
In the last couple of years the Gross Margin of CY4 has remained more or less at the same level.
CY4 does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 48.18%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.65%
GM growth 5Y-0.54%
CY4.MI Yearly Profit, Operating, Gross MarginsCY4.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

4

2. Health

2.1 Basic Checks

CY4 does not have a ROIC to compare to the WACC, probably because it is not profitable.
There is no outstanding debt for CY4. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CY4.MI Yearly Shares OutstandingCY4.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M 20M
CY4.MI Yearly Total Debt VS Total AssetsCY4.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M

2.2 Solvency

CY4 has an Altman-Z score of 1.09. This is a bad value and indicates that CY4 is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.09, CY4 is doing worse than 69.31% of the companies in the same industry.
The Debt to FCF ratio of CY4 is 5.51, which is a neutral value as it means it would take CY4, 5.51 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of CY4 (5.51) is comparable to the rest of the industry.
CY4 has a Debt/Equity ratio of 0.29. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.29, CY4 perfoms like the industry average, outperforming 50.49% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF 5.51
Altman-Z 1.09
ROIC/WACCN/A
WACC8.62%
CY4.MI Yearly LT Debt VS Equity VS FCFCY4.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

CY4 has a Current Ratio of 1.61. This is a normal value and indicates that CY4 is financially healthy and should not expect problems in meeting its short term obligations.
CY4 has a better Current ratio (1.61) than 66.34% of its industry peers.
A Quick Ratio of 1.59 indicates that CY4 should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.59, CY4 is doing good in the industry, outperforming 68.32% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.61
Quick Ratio 1.59
CY4.MI Yearly Current Assets VS Current LiabilitesCY4.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 21.72% over the past year.
Looking at the last year, CY4 shows a quite strong growth in Revenue. The Revenue has grown by 13.37% in the last year.
Measured over the past years, CY4 shows a very strong growth in Revenue. The Revenue has been growing by 59.24% on average per year.
EPS 1Y (TTM)21.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5.3%
Revenue 1Y (TTM)13.37%
Revenue growth 3Y61.94%
Revenue growth 5Y59.24%
Sales Q2Q%9.32%

3.2 Future

Based on estimates for the next years, CY4 will show a very strong growth in Earnings Per Share. The EPS will grow by 43.61% on average per year.
CY4 is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.63% yearly.
EPS Next Y52.91%
EPS Next 2Y47.05%
EPS Next 3Y43.61%
EPS Next 5YN/A
Revenue Next Year7.97%
Revenue Next 2Y2.57%
Revenue Next 3Y7.63%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CY4.MI Yearly Revenue VS EstimatesCY4.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M 100M
CY4.MI Yearly EPS VS EstimatesCY4.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

CY4 reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 120.03, the valuation of CY4 can be described as expensive.
CY4's Price/Forward Earnings is on the same level as the industry average.
CY4's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 37.64.
Industry RankSector Rank
PE N/A
Fwd PE 120.03
CY4.MI Price Earnings VS Forward Price EarningsCY4.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CY4 is on the same level as its industry peers.
Based on the Price/Free Cash Flow ratio, CY4 is valued cheaper than 87.13% of the companies in the same industry.
Industry RankSector Rank
P/FCF 14.12
EV/EBITDA 51.77
CY4.MI Per share dataCY4.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CY4 does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as CY4's earnings are expected to grow with 43.61% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y47.05%
EPS Next 3Y43.61%

More info and screens

0

5. Dividend

5.1 Amount

CY4 does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CY4GATE SPA

BIT:CY4 (7/25/2025, 5:19:08 PM)

4.91

-0.05 (-1.01%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners13.91%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap115.73M
Analysts86.67
Price Target5.66 (15.27%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 120.03
P/S 1.13
P/FCF 14.12
P/OCF 9.82
P/B 1.17
P/tB 6.46
EV/EBITDA 51.77
EPS(TTM)-0.68
EYN/A
EPS(NY)0.04
Fwd EY0.83%
FCF(TTM)0.35
FCFY7.08%
OCF(TTM)0.5
OCFY10.18%
SpS4.34
BVpS4.2
TBVpS0.76
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.19%
ROE -17.68%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 48.18%
FCFM 8.01%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.65%
GM growth 5Y-0.54%
F-ScoreN/A
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF 5.51
Debt/EBITDA 10.26
Cap/Depr 17.12%
Cap/Sales 3.5%
Interest Coverage N/A
Cash Conversion 422.73%
Profit Quality N/A
Current Ratio 1.61
Quick Ratio 1.59
Altman-Z 1.09
F-ScoreN/A
WACC8.62%
ROIC/WACCN/A
Cap/Depr(3y)19.8%
Cap/Depr(5y)17.04%
Cap/Sales(3y)4.99%
Cap/Sales(5y)3.77%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)21.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5.3%
EPS Next Y52.91%
EPS Next 2Y47.05%
EPS Next 3Y43.61%
EPS Next 5YN/A
Revenue 1Y (TTM)13.37%
Revenue growth 3Y61.94%
Revenue growth 5Y59.24%
Sales Q2Q%9.32%
Revenue Next Year7.97%
Revenue Next 2Y2.57%
Revenue Next 3Y7.63%
Revenue Next 5YN/A
EBIT growth 1Y-32.18%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year3400%
EBIT Next 3Y258.31%
EBIT Next 5YN/A
FCF growth 1Y-50.75%
FCF growth 3YN/A
FCF growth 5Y87.64%
OCF growth 1Y-42.43%
OCF growth 3YN/A
OCF growth 5Y43.36%